Is haematopoietic stem cell transplantation a treatment option for severe MS or not?

Brain

Volumn 130, Issue 5, 2007, Pages 1181-1182

  Martin, Roland ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BETA INTERFERON; BUSULFAN; CD8 ANTIGEN; CLADRIBINE; FINGOLIMOD; GLATIRAMER; IMMUNOSUPPRESSIVE AGENT; MITOXANTRONE; NATALIZUMAB;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AXONAL INJURY; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; DEMYELINATION; DISEASE ACTIVITY; DRUG TREATMENT FAILURE; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MACROPHAGE; MICROGLIA; MORTALITY; MULTIPLE SCLEROSIS; MYELOABLATIVE CONDITIONING; NOTE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RISK BENEFIT ANALYSIS; TRANSPLANTATION TOLERANCE; WHOLE BODY RADIATION; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; RISK;

CD8-POSITIVE T-LYMPHOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; LYMPHOCYTE ACTIVATION; MACROPHAGES; MULTIPLE SCLEROSIS; RISK; TRANSPLANTATION, AUTOLOGOUS;

EID: 34249724415     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm088     Document Type: Note

References (7)

1. Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, et al. The window of therapeutic opportunity in multiple sclerosis. Evidence from monoclonal antibody therapy. J Neurol 2005; 253: 98-108.
2. Mancardi GL, Saccardi R, Filippi M, Gualandi F, Murialdo A, Inglese M, et al. Autologous hematopoietic stem cell transplantation suppress Gd-enhanced MRI activity in MS. Neurology 2001; 57: 62-8.
3. Metz I, Lucchinetti C, Openshaw H, Garcia-Merino A, Lassmann H, Freedman M, et al. Autolougous hematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 2007; 130: 1254-62.
4. Muraro PA, Cassiani-Ingoni R, Martin R.. Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges. Curr Opin Neurol 2003; 16: 299-305.
5. Muraro PA, Douek DC, Packer A, Cheng K, Guenaga FJ, Cassiani-Ingoni R, et al. Thymic output generates a new and diverse TCR repertoire alter autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805-16.
6. Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, et al. Autologous stem cell tranplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Multiple Scler 2006; 12: 814-23.
7. Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P, et al. Autologous haematopoietic stem cell transplants for autoimmune diseases - feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant 1999; 24: 729-34.